AT9283
|
AT9283
|
896466-04-9
|
SAR407899 hcl
|
6-(哌啶-4-氧基)異喹啉-1(2H)-酮鹽酸鹽
|
923262-96-8
|
Prexasertibdihydrochloride
|
CHK1抑制劑
|
1234015-54-3
|
THZ1
|
THZ1
|
1604810-83-4
|
AZD-6094 (VOLITINIB)
|
沃利替尼
|
1313725-88-0
|
ML264
|
(2E)-3-(3-氯苯基)-N-[2-[甲基(四氫-1,1-二氧代-2H-噻喃-4-基)氨基]-2-氧代乙基]-2-丙烯酰胺
|
1550008-55-3
|
evobrutinib
|
埃沃布魯替尼
|
1415823-73-2
|
AD80
|
AD80
|
1384071-99-1
|
Seliciclib
|
細胞周期蛋白B激酶抑制劑
|
186692-46-6
|
KGA-2727
|
KGA2727
|
666842-36-0
|
YO01027
|
二苯并氮卓
|
209984-56-5
|
fluoroclebopride
|
4-氨基-5-氯-N-[1-[(4-氟苯基)甲基]-4-哌啶基]-2-甲氧基苯甲酰胺
|
154540-49-5
|
R1487
|
SY-R1487
|
449808-64-4
|
KRCA-0008
|
1,1'-((((5-氯嘧啶-2,4-二基)雙(氮烷二基))雙(3-甲氧基-4,1-亞苯基))雙(哌嗪-4,1-二基))雙(乙-1-酮)
|
1472795-20-2
|
IOX4
|
TERT-BUTYL 6-(5-OXO-4-(1H-1,2,3-TRIAZOL-1-YL)-2,5-DIHYDRO-1H-PYRAZOL-1-YL)NICOTINATE
|
1154097-71-8
|
Blu-285
|
Avapritinib (BLU-285) ;BLU-285-P2活性
|
1703793-34-3
|
Debio-0617B
|
Debio 0617B
|
1332329-27-7
|
Inarigivir
|
SB9000
|
475650-36-3
|
AC1903
|
AC1903
|
831234-13-0
|
AZ-3451
|
(S)-2-(6-溴苯并[D][1,3]二氧雜環(huán)戊烯-5-基)-N-(4-氰基苯基)-1-(1-環(huán)己基乙基)-1H-苯并[D]咪唑-5-甲酰胺
|
2100284-59-9
|
LACS-13909
|
4-Piperidinamine, 1-[3-(2,3-dichlorophenyl)-1H-pyrazolo[3,4-b]pyrazin-6-yl]-4-methyl-
|
2160546-07-4
|
GF109203X
|
GF109203X
|
133052-90-1
|
XL335
|
3-(3,4-二氟苯甲?;?-1,2,3,6-四氫-1,1-二甲基氮雜卓[4,5-B]吲哚-5-甲酸 1-甲基乙基酯
|
629664-81-9
|
TUG-891
|
TUG 891
|
1374516-07-0
|
UNC2025
|
反式-4-[2-(丁基氨基)-5-[4-[(4-甲基-1-哌嗪基)甲基]苯基]-7H-吡咯并[2,3-D]嘧啶-7-基]-環(huán)己醇
|
1429881-91-3
|
Pexmetinib
|
PEXMETINIB
|
945614-12-0
|
SAR-20347
|
CPDD1211
|
1450881-55-6
|
H3B-6527
|
H3B-6527
|
1702259-66-2
|
Benvitimod
|
苯烯莫德
|
79338-84-4
|
JZL195
|
4-硝基苯基4-(3-苯氧基芐基)哌嗪-1-甲酸叔丁酯
|
1210004-12-8
|
AZD3463
|
AZD3463
|
1356962-20-3
|
AZD2858
|
AZD2858
|
486424-20-8
|
ZM306416
|
N-(4-氯-2-氟苯基)-6,7-二甲氧基-4-喹唑啉胺
|
690206-97-4
|
pardoprunox.HCl
|
鹽酸帕多蘆諾
|
269718-83-4
|
BIX-01294
|
BIX 01294
|
935693-62-2
|
PF-573228
|
6-[(4-((3-(甲磺?;?芐基)氨基)-5-三氟甲基嘧啶-2-基)氨基]-3,4-二氫-1H-喹啉-2-酮
|
869288-64-2
|
PD-166866
|
PD-166866
|
192705-79-6
|
Compound E
|
N-[(1S)-2-[[(3S)-2,3-二氫-1-甲基-2-氧代-5-苯基-1H-1,4-苯并二氮雜卓-3-基]氨基]-1-甲基-2-氧代乙基]-3,5-二氟苯乙酰胺
|
209986-17-4
|
kevetrin.HCl
|
KEVETRIN, NSC 525990
|
66592-89-0
|
Blu-782
|
BLU-782
|
2141955-96-4
|
5'-DMT-2'-TBDMS-BZ-RA
|
5'-DMT-2'-TBDMS-BZ-RA
|
81265-93-2
|
BGJ-398
|
FGFR抑制劑(NVP-BGJ398)
|
872511-34-7
|
LR-90
|
2,2' - ((((((亞甲基雙(2-氯-4,1-亞苯基))二(氮烷二基))二(羰基))雙(氮烷二
|
245075-84-7
|
KO3861
|
K03861
|
853299-07-7
|
TBPB
|
5MG
|
634616-95-8
|
APD597
|
APD597
|
897732-93-3
|
APY29
|
APY29
|
1216665-49-4
|
OTSSP167.HCl
|
OTSSP 167 鹽酸鹽
|
1431698-10-0
|
LY2584702
|
LY-2584702
|
1082949-67-4
|
GSK2982772
|
GSK2982772
|
1622848-92-3
|
NSC5844
|
N,N'-雙(7-氯-4-喹啉)-1,2-乙二胺
|
140926-75-6
|
SHP099
|
SHP-099游離
|
1801747-42-1
|
CYC065
|
CYC-065
|
1070790-89-4
|
PK-10571
|
3-Pyridinecarboxamide, N-[3-[(1S)-1-[[6-(3,4-dimethoxyphenyl)-2-pyrazinyl]amino]ethyl]phenyl]-5-methyl-
|
1619931-27-9
|
PD153035.HCl
|
PD153035 HCl
|
183322-45-4
|
eptapirone
|
F 11440
|
179756-58-2
|
Alisertib (MLN8237)
|
阿立塞替
|
1028486-01-2
|
AMG-47a
|
4-甲基-3-[2-[[2-(4-嗎啉基)乙基]氨基]-6-喹唑啉基]-N-[3-(三氟甲基)苯基]苯甲酰胺
|
882663-88-9
|
PD-161570
|
PD-161570;PF-1480232
|
192705-80-9
|
FH535
|
2,5-二氯-N-(2-甲基-4-硝基苯基)苯磺酰胺
|
108409-83-2
|
GSK2334470
|
GSK2334470
|
1227911-45-6
|
ALK inhibitor 2
|
2-[[5-氯-2-[[2-甲氧基-4-(4-甲基-1-哌嗪基)苯基]氨基]-4-嘧啶基]氨基]-N-甲基苯磺酰胺
|
761438-38-4
|
Rigosertibsodium
|
瑞格色替鈉
|
592542-60-4
|
INCB8761(PF-4136309)
|
INCB8761(PF-4136309)
|
1341224-83-6
|
URMC-099
|
URMC-099
|
1229582-33-5
|
PRN-1371
|
PRN1371
|
1802929-43-6
|
BPH-715
|
BPH-715
|
1059677-23-4
|
FM-381
|
(E)-2-CYANO-3-(5-(1-CYCLOHEXYL-1,6-DIHYDROIMIDAZO[4,5-D]PYRROLO[2,3-B]PYRIDIN-2-YL)FURAN-2-YL)-N,N-DIMETHYLACRYLAMIDE
|
2226521-65-7
|
PNU282987.HCl
|
PNU-282987
|
123464-89-1
|
EMD-1214063
|
特泊替尼
|
1100598-32-0
|
GDC-0623
|
GDC-0623
|
1168091-68-6
|
Hydrazinium hydroxide
|
4-(5-氯-2-乙氧基-4-氟苯甲酰氨基)-3,3-二甲基丁酸
|
1805818-57-8
|
PD-173955
|
6-(2,6-二氯苯基)-8-甲基-2-[[3-(甲硫基)苯基]氨基]吡啶并[2,3-D]嘧啶-7(8H)-酮
|
260415-63-2
|
CB-103
|
6-[4-(叔丁基)苯氧基]吡啶-3-胺
|
218457-67-1
|
SGI-1776
|
SGI-1776
|
1025065-69-3
|
slx-2119
|
2-[3-[4-[(1H-吲唑-5-基)氨基]喹唑啉-2-基]苯氧基]-N-異丙基乙酰胺
|
911417-87-3
|
4SC-202
|
4SC-202(鹽的形式)
|
1186222-89-8
|
FRAX486
|
FRAX486
|
1232030-35-1
|
LY 2606368
|
5-[[5-[2-(3-氨基丙氧基)-6-甲氧基苯基]-1H-吡唑-3-基]氨基]-2-吡嗪甲腈
|
1234015-52-1
|
cerdulatinib
|
賽度替尼
|
1198300-79-6
|
BLU-9931
|
BLU 9931
|
1538604-68-0
|
poseltinib
|
奧莫替尼
|
1353562-97-2
|
GDC0575
|
(R)-N-(4-(3-氨基哌啶-1-基)-5-溴-1H-吡咯并[2,3-B]吡啶-3-基)環(huán)丙烷甲酰胺
|
1196541-47-5
|
THZ-531
|
THZ531
|
1702809-17-3
|
pipequaline.HCl
|
鹽酸哌夸林
|
80221-58-5
|
Autophinib
|
6-CHLORO-N-(5-METHYL-1H-PYRAZOL-3-YL)-2-(4-NITROPHENOXY)PYRIMIDIN-4-AMINE
|
1644443-47-9
|
Lanraplenib (GS-9876)
|
GS-9876
|
1800046-95-0
|
MCC7840 sodium
|
N-[[(1,2,3,5,6,7-hexahydro-s-indacen-4-yl) amino]carbonyl]-1-(1-methylethyl)-1H-Pyrazole-3-sulfonamide
|
1995067-59-8
|
PD-166285
|
6-(2,6-二氯苯基)-2-[[4-[2-(二乙基氨基)乙氧基]苯基]氨基]-8-甲基吡啶并[2,3-D]嘧啶-7(8H)-酮鹽酸鹽
|
212391-63-4
|
WYE 354
|
4-[6-[4-[(甲氧羰基)氨基]苯基]-4-(4-嗎啉基)-1H-吡唑并[3,4-D]嘧啶-1-基]-1-哌啶羧酸甲酯
|
1062169-56-5
|
PP242
|
PP242
|
1092351-67-1
|
BIX 01294 Trihydrochloride Hydrate
|
BIX 01294三鹽酸鹽水合物
|
1392399-03-9
|
GS9973
|
GS-9973
|
1229208-44-9
|
UNC0379
|
UNC0379
|
1620401-82-2
|
RQ00203078
|
4-(N-(3-氯-5-(三氟甲基)吡啶-2-基)-N-(4-(三氟甲氧基)芐基)氨基磺酰基)苯甲酸
|
1254205-52-1
|
NVP-BAW2881
|
BAW2881
|
861875-60-7
|
HA-15
|
HA-15
|
1609402-14-3
|
DMX-5084
|
DMX5804;DMX 5804
|
2306178-56-1
|
PD173074
|
PD173074
|
219580-11-7
|
nifenalol.HCl
|
1-(4-硝基苯基)-1-羥基-2-異丙基氨基乙烷鹽酸鹽
|
5704-60-9
|